Progyny Revenue and Competitors
Estimated Revenue & Valuation
- Progyny's estimated annual revenue is currently $473.4M per year.
- Progyny received $10.0M in venture funding in May 2017.
- Progyny's estimated revenue per employee is $829,019
- Progyny's total funding is $115.5M.
- Progyny's current valuation is $3.9B. (January 2022)
Employee Data
- Progyny has 571 Employees.
- Progyny grew their employee count by 29% last year.
Progyny's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Group VP, Marketing | Reveal Email/Phone |
2 | VP | Reveal Email/Phone |
3 | Group VP for Labor | Reveal Email/Phone |
4 | CEO | Reveal Email/Phone |
5 | VP, Operations - Member & Provider Services | Reveal Email/Phone |
6 | VP Account Management | Reveal Email/Phone |
7 | SVP, Employer Market Strategy | Reveal Email/Phone |
8 | SVP Business Development | Reveal Email/Phone |
9 | VP Employer Partnerships | Reveal Email/Phone |
10 | VP, National Accounts | Reveal Email/Phone |
Progyny Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $120M | 675 | 8% | $315M | $1.8B |
#2 | $75.7M | 255 | 31% | N/A | N/A |
#3 | $13.5M | 93 | 15% | N/A | N/A |
What Is Progyny?
Progyny is the leading fertility benefits company that combines service, science, technology and data to provide fertility solutions for self-insured employers. Progyny's approach offers members a comprehensive value based treatment plan that is based on the latest medical science and technology. The benefit plans are designed to improve outcomes, shorten time to pregnancy and reduce total fertility-related costs. Progyny supports all fertility solutions to include IVF, IUI, embryo banking, egg freezing, adoption and surrogacy.
keywords:Biotechnology,Hardware,Healthcare,Healthcare Providers,Pharmaceuticals
$115.5M
Total Funding
571
Number of Employees
$473.4M
Revenue (est)
29%
Employee Growth %
$3.9B
Valuation
N/A
Accelerator
Progyny News
Analysts expect Progyny to post earnings of $0.02 per share for the quarter. Progyny has set its Q1 2022 guidance at $-0.020-$-0.010 EPS and its...
Progyny, Inc. to Present at the BofA Securities 2022 Healthcare Conference. by Globe Newswire. April 28, 2022 5:00 PM | 1 min read.
NEW YORK, April 19, 2022 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a leading benefits management company specializing in fertility...
26 Oct Blog, Surrogacy/Adoption, Let's Talk Fertility, Emotional Support + Awareness Progyny Celebrates National Adoption Awareness Month Posted on October 26, 2021October 26, 2021by Shannon Zuber October 26 At Progyny, we believe everyone who wants to have a child should be able to do so a ...
21 Jul Blog, Let's Talk Fertility Progyny Webinar: Journey to Fatherhood: Same-sex Couples + Single Fathers by Choice Posted on July 21, 2021July 21, 2021by Elizabeth Foot July 21 Join us for the the third and final installment in Progyny's three-part Journey to Fatherhood webinar series di ...
Other Companies in New York
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $192.7M | 571 | 35% | N/A |
#2 | $94.4M | 572 | 30% | $1.3M |
#3 | $100.3M | 573 | 36% | N/A |
#4 | $100.3M | 573 | N/A | N/A |
#5 | $107.4M | 573 | 48% | N/A |
Progyny Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2016-06-30 | $15.0M | Undisclosed | Kleiner Perkins Caufield and Byers | Article |
| 2017-05-03 | $10.0M | B | Kleiner Perkins Caufield and Byers | Article |